Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

NCT00622674 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Masonic Cancer Center, University of Minnesota